QRX qrxpharma ltd
Add to My Watchlist 0.00% ! 2.8¢

actavis deal

  1. pgabz
    299 Posts.
    clock Created with Sketch.
    12/09/12
    14:25
    Post #: 10707997
    the NDA for moxduoIR is to be refiled with the FDA with an expected decision in mid 2013.

    previous presentations indicate that actavis was 'gearing up' in anticipation of earlier approval by employing additional sales staff etc. clearly that will have to be rewound. it appears atcavis will bear the cost of the delay at first instance. will those costs be borne by qrx when its entitlement to royalties are caculated?can anyone explain the basis on which royalties to qrx are calculated?
    QRX Price at posting: 68.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.